Each train's product matrix, its re-checks and the study plans they sign
- The impact of a new product seen on the equipment
- Exposure limits back as fields, not email
- A plan that lists what still blocks it
Cleaning validation kept current on shared trains: when a product enters, agents recompute each carryover limit, re-rank the worst case and check every swab site, then the lead and QA sign.
Follow one new product onto a shared train ↓In a contract plant, many client products share one equipment train. Each residue limit on it depends on the next product's batch and daily dose, the previous product's exposure limit, the train's whole contact area and each swab site's recovery. When technology transfer adds a product, the lead types one new row into the matrix spreadsheet and redoes the governing pair.
The client's exposure limit is still to be provided and arrives later as a PDF in an email thread. Whether the old study covers the new limits is judged by eye. Results that no longer meet them surface at the first clean after the new product, or in front of an inspector.
Built forCleaning validation leadsValidation engineersQC analystsToxicologists
A new product on a shared train changes the carryover limit of each product before it, and old swab results go unread against the new limits.
Redone by hand for each product
Built-in controls
Each new client product enters a shared train with its residue limits recomputed and its study planned before its first batch.
A client's new tablet enters a shared granulation, compression and coating train, and validation, toxicology and QA each act on the re-check.
demoThe plant, its client products, the toxicologists and every limit shown are sample data.
Validation runs the re-check and the study, QC owns what a swab can measure, and toxicology decides which exposure limits the sums use.
Each train's product matrix, its re-checks and the study plans they sign
Start re-checks, answer challenger points, approve verification results
Swab and rinse methods, recovery studies, quantitation limits and results
Read each client exposure report before a limit is computed from it
The site the challenger corrected, the question only a person could answer, a rehearsal, the week's verifications, every train, and the signatures.
demoSample data, from the working solution.
Cleaning validation is documented proof that a cleaning procedure removes each product's residue to a limit that protects the next product made on the same equipment. Here agents keep that proof current on shared trains: when a product enters, they recompute each carryover limit, re-rank the worst case and compare the results on file with the new limits.
For each pair, the residue's exposure limit times the next product's batch size, divided by that product's largest daily dose, gives the health-based limit. A parts-per-million limit on the next batch is computed beside it, and the lower one is taken. The lowest pair sets the train's limit, which is spread over the whole product-contact area and then over each swab.
On solubility, cleanability and toxicity, as EU GMP's annex on qualification and validation asks for shared equipment. The agents re-score each product when one enters and say whether the validated marker still covers the newcomer; a hard-to-clean product can become the worst case before its exposure limit is known.
Recovery is measured per material in the approved recovery study, and a factor copied from stainless steel onto a gasket makes that site's limit look looser than it is. The challenger checks each site's material against the study before the plan can be signed.
No health-based limit is computed from it. The agents draft a structured request to the client's toxicologist, the lead sends it, and the CDMO's toxicologist accepts the answer only after opening the signed report and seeing the factors reproduce it.
Yes. Until the study report is signed, each clean before and after the new product is swabbed at every site, and the next batch cannot be charged until QC's results are approved by someone who did not enter them.
Risk files that move with the evidence, so no score rests on a control that stopped working.
1-min demoGMP Inspection ReadinessThe record gap is found by your own back room, disclosed and logged, before an investigator reads the page.
1-min demoContamination Control Strategy (Annex 1)A weak barrier shows the day its records change, not at the yearly review.
1-min demoSend one train's product register, validation report and recovery study, and we will re-check its limits pair by pair.